FARICIMAB-SVOA for Retinal neovascularisation: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 18 adverse event reports in the FDA FAERS database where FARICIMAB-SVOA was used for Retinal neovascularisation.

Most Reported Side Effects for FARICIMAB-SVOA

Side Effect	Reports	%	Deaths	Hosp.
Off label use	453	23.7%	27	28
No adverse event	259	13.6%	0	0
Death	158	8.3%	153	1
Visual impairment	146	7.7%	1	15
Eye inflammation	136	7.1%	0	5
Blindness	127	6.7%	0	8
Endophthalmitis	125	6.6%	1	9
Uveitis	102	5.4%	0	12
Vitritis	90	4.7%	0	13
Drug ineffective	82	4.3%	0	3
Vision blurred	80	4.2%	0	10
Iridocyclitis	76	4.0%	0	9
Vitreous floaters	65	3.4%	0	3
Eye pain	61	3.2%	0	10
Retinal haemorrhage	51	2.7%	0	3